CRESCENT BIOPHARMA, INC. Earnings Per Share Diluted

Quick Answer

CRESCENT BIOPHARMA, INC. reported Earnings Per Share Diluted of $0.59 (loss) per share for the year ending 2024.

  • CRESCENT BIOPHARMA, INC. showed a decrease of -1.7% in Earnings Per Share Diluted from 2023 to 2024.
  • This data is from CRESCENT BIOPHARMA, INC.'s annual report (Form 10-K), filed with the SEC on February 13, 2025.
  • XBRL data for this metric is available from 2012 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2012 to 2024), CRESCENT BIOPHARMA, INC.'s Earnings Per Share Diluted has declined by 278.8%.
  • Historical annual values: Fiscal year 2024: $0.59 (loss) per share | Fiscal year 2023: $0.58 (loss) per share | Fiscal year 2022: $0.89 (loss) per share | Fiscal year 2021: $1.23 (loss) per share | Fiscal year 2020: $1.12 (loss) per share | Fiscal year 2019: $1.34 (loss) per share | Fiscal year 2014: $0.60 (loss) per share | Fiscal year 2013: $8.87 (loss) per share | Fiscal year 2012: $0.33 per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: